inside

ללא קטגוריה

INSIGHTEC’S EXABLATE SYSTEM SPARES THE UTERUS WHEN TREATING UTERINE FIBROIDS

INSIGHTEC announced on Wednesday that the FDA has approved the relabelling of the Exablate system to treat women with symptomatic uterine fibroids who want to spare their uterus and maintain fertility. Exablate can now be used for both women who are “family complete” and those who still want to conceive. Link to article

More Articles

ללא קטגוריה
ללא קטגוריה

MRgFUS FEATURED ON RADIOLOGY TODAY ‘S COVER

ללא קטגוריה
ללא קטגוריה

NEW ENGLAND JOURNAL OF MEDICINE ARTICLE RECOMMENDS FOCUSED ULTRASOUND FOR UF

שינוי גודל גופנים